mk-0616
merck
[]
amazing results from a placebo controlled trial (iib) of an oral pcsk9 inhibitor led by dr. ballantyne showing 60% reduction of ldl levels after 8 wks. #acc2023 #wcc2023 #nola 
Internist |🫀Incoming Cardiology Fellow at Baylor College of Medicine @BCMHeart @BCMHouston | IM RGH | Husband, Explorer, First Gen MD | IG: bryantan_md 🇲🇾